A $5 million prize awaits proof that quantum computers can solve health care problems

Foto: MIT Tech Review
# Five Million Dollar Prize for Quantum Computing Healthcare Breakthrough Five million dollars awaits the team that proves quantum computers can solve real-world problems in healthcare. The competition, details of which MIT Technology Review is revealing, represents an attempt to break the impasse between promising technology and its practical medical application. For years, quantum computers remained in the realm of theory and laboratory experiments. Manufacturers such as IBM and Google have impressed the world, but the medical industry has been waiting for concrete evidence that these devices can actually accelerate drug development, optimize treatment plans, or analyze complex genetic data faster than traditional supercomputers. The prize is being offered by a consortium of interested parties — from technology companies to healthcare organizations. The goal is to stimulate innovation and demonstrate where quantum computing can deliver real value for patients. The winner will need to demonstrate a measurable advantage over classical methods in a specific medical problem. This is a signal that the tech industry is moving from hype to verification. Quantum computers must now prove their usefulness, not just their technical capabilities.
In a laboratory on the outskirts of Oxford stands a device that could change the entire healthcare industry. A quantum computer built from atoms and light, with a hundred cesium atoms suspended in a lattice by carefully manipulated electromagnetic fields — this is not science fiction, it is a reality that scientists are already observing today. But there is a catch: nobody knows whether this technology will actually solve any practical problems in medicine. That is precisely why research institutions and technology funds are offering five million dollars to a team that proves quantum computers can actually bring measurable value to healthcare. This is not just any award — it is an admission that despite decades of investment and hype, the industry is still searching for proof that this technology is not merely an expensive experiment.
A large part of the technology world is convinced that quantum computers will be revolutionary. Giants like IBM, Google, and Amazon are investing billions in their development. But there is something fundamentally wrong with this narrative: everyone talks about potential, nobody talks about real applications that already work. In healthcare, the situation is particularly paradoxical. Medicine is one of the fields where theoretically quantum computers could work wonders — drug optimization, protein modeling, analysis of enormous genetic datasets. Except nobody has done it. That is precisely why this award is so important: it is essentially an admission that the industry must find proof of the concept it has been selling for the last fifteen years.
The collision wall between theory and practice
Quantum computers operate on completely different principles than traditional computers. Instead of bits (zeros and ones), they use qubits, which can be both zero and one simultaneously thanks to quantum superposition. Theoretically, this means they can solve certain problems exponentially faster than classical computers. But here theory ends and reality begins. Today's quantum computers are extremely unstable, prone to errors, and require conditions close to absolute zero. Even the slightest vibration, temperature change, or electromagnetic field fluctuation can destroy the calculations.
Read also
In practice, this means that current quantum computers can perform calculations for a few minutes before quantum errors (decoherence) render them useless. By comparison: classical computers can work continuously for years. This difference is enormous when thinking about real medical problems. If you want to model how a drug binds to a protein, you need stability, not a few-minute window full of errors.
This is precisely the collision wall that scientists speak of. Every article about quantum computers talks about what they can do in theory. Almost none talk about the fact that these devices are practically useless for most real problems. The five million dollar award is an attempt to shift this conversation from "can" to "do".
Healthcare as a battlefield for quantum
Why healthcare specifically? Because it is one of the few fields where the potential benefits of quantum computers are both theoretically possible and practically significant. Take drug discovery, for example. Today pharmaceutical companies test thousands of chemical compounds to find the one that will work. This takes years and costs billions. A quantum computer could theoretically simulate these interactions at the molecular level and point to the most promising candidates in a fraction of the time.
Or take genomics. DNA sequencing is no longer a problem — we can do it quickly and cheaply. The problem appears when you want to analyze genetic data from millions of people to find patterns associated with diseases. This requires processing enormous datasets and finding correlations in the noise. Quantum computers could theoretically do this much faster. But the key word is "theoretically".
Polish healthcare, like many systems in Europe, struggles with insufficient resources and outdated IT infrastructure. The idea of quantum computers solving the problems of Polish hospitals is therefore particularly abstract. But if this technology ever works, it is precisely in such contexts — in optimizing resource allocation, predicting epidemics, personalizing treatment — that it could bring real value.
The game of prestige and funding
The five million dollar award is not just an incentive for innovation. It is also a political and business game. The institutions offering this money — including venture capital funds, governments, and large technology corporations — have their own interests. They want to show that investments in quantum computers are producing results. If a team from university X or startup Y proves that quantum computers can accelerate drug discovery or improve diagnostics, it will be enormous PR for the entire industry.
On the other hand, it is also an admission of failure. For years the quantum industry has talked about a breakthrough that is always "five years away". Now, after already waiting fifteen years, someone finally says: "Okay, give us proof". This is a shift in narrative from optimism to pragmatism. This is not bad — quite the opposite, it is healthy. But it shows that even the largest research institutions are beginning to lose patience.
For Polish startups and scientists, this award could be interesting if there were the ability to compete on the international stage in this field. Unfortunately, Poland does not have a significant ecosystem for quantum computer research. A few academic centers conduct theoretical work, but there are no serious hardware projects here. This means that for Polish teams this award is practically inaccessible — unless someone can afford to collaborate with international partners.
Evaluation criteria: what counts as "success"?
Here another question arises: how will success be defined? If a quantum computer speeds up calculations by 10%, does that count as a breakthrough? Or does it need to be 100 times faster? Is it enough to theoretically demonstrate that it is possible, or must there be a real system operating in production? The evaluation criteria for this award will be crucial, and at the same time extremely difficult to establish.
The problem is that quantum computers are good at very specific types of problems — mainly optimization and factorization. But in healthcare most problems are not purely quantum. They require a hybrid approach, where the quantum computer does part of the work and the classical computer does the rest. This makes comparing performance very difficult. It may turn out that the quantum computer accelerates part of the process, but the total benefit is marginal, because the remaining parts of the process are the bottleneck.
The question everyone asks in silence is: will this award even be given? Will there be a team that meets the criteria? Or might it turn out that the conditions are too difficult to meet, and the award remains unattained? This would be a blow to the industry — an admission that quantum computers are not yet ready for real applications.
Competition and alternatives
While the industry waits for a breakthrough in quantum computers, traditional computers are making stunning progress. Artificial intelligence, particularly large language models and neural networks, are already solving problems in healthcare today. Algorithms for cancer diagnosis, predicting heart disease, or even discovering new drugs — it all works now, today, on classical computers. There is no need to wait for quantum computers.
This is the real problem for the quantum industry. How will investments in quantum computers be justified if AI is already doing what quantum computers promised? The answer is that there are problems that AI will not solve, but quantum computers can. The problem is that nobody can clearly explain what those problems are, and why they cannot be solved by other methods.
In the Polish context, where technology investments are limited, the question of alternatives is particularly relevant. Is it better to invest in quantum computers or in AI? The answer is obvious: in AI. At least now, when AI is already producing results and quantum computers are still waiting for their moment.
Realistic scenarios for the next five years
If the award is given, it will mean that a quantum computer solved a specific medical problem better than classical computers. But it will not mean that quantum computers are ready for mass deployment. It will mean that in one, very specific case, this technology worked. Such scenarios are possible: for example, modeling a protein in a specific drug, or optimizing a treatment schedule for a specific type of cancer.
More likely is that the award will be given for something less spectacular — for example, for showing that a quantum computer can accelerate part of the drug discovery process, even if the total benefit is small. This would be enough for the industry to say: "Look, it works!"
The least likely scenario is one where nobody wins the award. This would be the biggest blow to the quantum industry, but also the most honest admission that this technology is not yet ready. Such a failure could lead to a significant reduction in funding for quantum computer research, at least in the medical sector.
A lesson for the entire technology industry
This award is also a lesson for the entire technology industry. Namely: hype does not replace reality. For years quantum computers were promoted as the future, as technology that would change everything. Media wrote about them like a miracle cure. But when it came to real applications, it turned out there were none. Now the industry is admitting this, offering money for proof that this technology does anything at all.
This is an important lesson for anyone who invests in technology. Hype is cheap and easy to produce. Real results are difficult and take time. Quantum computers may be the future, but that future is much more distant than the dream sellers told us.
For Polish technology companies, startups, and investors, this story should be a memento. Instead of chasing the latest trends, it is better to focus on real problems that can be solved today. AI, blockchain, IoT — all these technologies have real applications already now. Quantum computers are cool in theory, but in practice they are still a child that requires years of care before it can walk on its own.







